Eli Lilly announced a new $27bn US manufacturing commitment on 26 February alongside top Trump Administration officials at the Andrew W. Mellon Auditorium in Washington DC. (Sarah Karlin-Smith)
Keep up with the top pharma business news of the week. On the go.
